Biotech and life sciences investors back companies advancing drug discovery, diagnostics, genomics, and therapeutics. This sector requires deep scientific expertise and comfort with longer investment horizons of 7-12 years. Key trends include AI-accelerated drug discovery, cell and gene therapies, mRNA platforms, and precision oncology. Investors evaluate scientific novelty, clinical pathway feasibility, regulatory strategy, and intellectual property moats.
No investors found for Biotech & Life Sciences.